La Celle Saint Cloud, France

Nicolas Guilbaud


Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Paris, FR (1995 - 1997)
  • La Celle Saint Cloud, FR (1999 - 2003)

Company Filing History:


Years Active: 1995-2003

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Nicolas Guilbaud

Introduction:

Nicolas Guilbaud is a talented inventor hailing from La Celle Saint Cloud, France. With an impressive portfolio of 7 patents to his name, his innovative spirit and passion for creating groundbreaking solutions have led to significant advancements in the field of pharmaceuticals.

Latest Patents:

One of his latest patents includes the development of Cycloheptene compounds - Carboxylic and hydroxamic acid compounds inhibiting metalloproteases. This invention explores a compound formula aimed at preparing pharmaceutical compositions that can effectively inhibit metalloproteases, showcasing Guilbaud's commitment to enhancing medicine.

Career Highlights:

Throughout his career, Nicolas Guilbaud has made significant contributions while working with renowned companies such as Adir et Compagnie and Les Laboratoires Servier. His dedication to innovation and scientific discovery has positioned him as a leading figure in the pharmaceutical industry.

Collaborations:

Guilbaud's collaborations with talented individuals like Alain Pierre and Ghanem Atassi have further enriched his innovative endeavors. The exchange of ideas and expertise among these professionals has undoubtedly played a pivotal role in the successful realization of various projects.

Conclusion:

In conclusion, Nicolas Guilbaud's relentless pursuit of innovation and his invaluable contributions to the field of pharmaceuticals have solidified his reputation as a visionary inventor. His patents stand as a testament to his ingenuity and unwavering commitment to advancing healthcare through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…